Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFatigue is one of the side effects reported during the STEP 1 clinical trial of semaglutide 2.4mg, affecting a meaningful proportion of participants alongside the more familiar gastrointestinal symptoms. If you are experiencing tiredness on Wegovy, you are not alone and you are not imagining it. For most people, fatigue with semaglutide is mild, tends to cluster around dose changes, and eases as the body adjusts — but knowing when it is expected and when it warrants a call to your prescriber makes a real difference. Semaglutide is a prescription-only medicine; a clinician assesses whether it is appropriate for you and discusses likely side effects as part of that process.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial, published in the New England Journal of Medicine, followed 1,961 adults over 68 weeks and remains the core evidence base for semaglutide 2.4mg in weight management. Fatigue appeared among the adverse events tracked, alongside the more widely discussed gastrointestinal effects. It was not among the most common reactions (nausea, diarrhoea and constipation occurred more frequently) but it was consistent enough to feature in the medicine's safety profile. The NHS patient information for semaglutide lists tiredness as a known side effect, which means healthcare professionals and regulators expected it before the medicine was licensed.
Why does it happen? If you have been wondering whether semaglutide can cause fatigue, the short answer is yes, and the physiology is fairly straightforward: semaglutide acts on GLP-1 receptors involved in appetite regulation and slows gastric emptying, so as calorie intake falls and the body shifts its energy balance, a period of tiredness is physiologically unsurprising. The effect is compounded when a dose increase prompts a new wave of nausea — being nauseous is tiring, full stop. Most people find the fatigue is at its worst in the day or two after a dose step-up, then drifts away as the body settles at the new level.
One practical check worth doing: note how many glasses of water you drank that day. Mild dehydration from reduced appetite or nausea-related low fluid intake can amplify tiredness considerably, and it is easy to underestimate on a day when food and drink feel unappealing. Keeping a small bottle in view and drinking steadily through the day costs nothing and often helps.
Most fatigue on semaglutide is unremarkable: you feel more tired than usual for a few days, particularly around the start of treatment or after a dose increase, then it passes. That pattern does not require any action beyond rest, good hydration and mentioning it at your next check-in.
There are situations where tiredness should prompt earlier contact with a prescriber or, in some cases, urgent medical help. The NHS England weight-management injections guidance sets out clearly that severe or persistent gastrointestinal symptoms can lead to dehydration, which in turn causes significant fatigue and, if unchecked, can affect kidney function. If your tiredness is accompanied by very reduced urination, dizziness on standing, or you cannot keep fluids down for more than a day, contact a healthcare professional the same day.
Fatigue paired with severe stomach pain that radiates to the back is a different matter. In January 2026 the MHRA issued a Drug Safety Update reminding prescribers and patients that acute pancreatitis, though infrequent, is a recognised risk with GLP-1 medicines; the hallmark symptom is intense, persistent abdominal pain that may reach the back, with or without vomiting. That combination needs emergency attention, not watchful waiting. Details on broader Wegovy side effects are covered separately if you want the fuller picture.
There is no single fix, but several things help in practice. Protein is the most useful dietary focus: when appetite falls sharply, total calorie intake drops, and protein is the macronutrient most likely to be under-eaten. Low protein intake accelerates muscle loss, which feeds fatigue. Aiming for a protein-containing food at each meal (eggs, fish, legumes, yoghurt, meat) gives your body what it needs to function without requiring a large volume of food.
Sleep quality matters more than people expect on this treatment. GLP-1 medicines can affect how quickly the stomach empties, and some people find late evening nausea disturbs sleep; eating the main meal earlier and keeping the evening light can reduce that. Light movement (a short walk, gentle stretching) is better than rest alone for fatigue that has a low-grade, draggy quality rather than acute exhaustion.
If fatigue continues beyond two to three weeks at a stable dose without an obvious explanation, it is worth raising with your prescriber rather than assuming it is just the medicine. Thyroid function, iron levels and vitamin B12 can all affect energy; none of these are caused by semaglutide, but starting a new treatment often prompts people to notice symptoms they had been ignoring. Some people also notice skin reactions at this stage, and reading about semaglutide side effects such as itching can help you work out whether what you are experiencing fits a recognised pattern. Explore what drives fatigue during semaglutide treatment for a closer look at the physiological mechanisms.
Most fatigue on semaglutide does not need emergency care. But some symptoms alongside tiredness do. Seek urgent help (the same day, or via 999 or A&E if severe) in any of these situations: persistent vomiting or diarrhoea leading to signs of dehydration (very dark urine, dizziness, confusion); severe abdominal pain that radiates to the back; difficulty breathing, swelling of the face or throat, or a rapid heartbeat that could indicate a serious allergic reaction; or sudden changes in vision if you also have diabetes.
For less urgent concerns, a fuller look at semaglutide side effects including fatigue can help you judge whether what you are experiencing is within the expected range or worth discussing sooner. For questions about whether a dose increase is right for you, contact your prescriber in the normal way. At nume, our clinical team is available for aftercare support seven days a week; you can reach the team via our contact page. If you experience a side effect you were not expecting, you can also report it directly to the MHRA using the Yellow Card scheme, which helps regulators monitor medicines in real-world use.
If you are considering semaglutide and want to understand more about the treatment before starting, the Wegovy overview page covers how it works and what to expect. Check your eligibility with our prescribers, who discuss suitability and expected side effects, including fatigue, as a standard part of the clinical consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.